Perceptive Advisors Turns Big Loss into Hefty Gain
Joseph Edelman’s biotech fund, whose performance landed him on the Rich List last year, was down by double digits this year but has since bounced back and then some.
Stephen TaubOctober 6, 2016
Joseph Edelman, Perceptive Advisors (Bloomberg) Now, this is what you call a comeback. The Perceptive Life Sciences Fund, managed by Joseph Edelman’s New York–based Perceptive Advisors, suffered a 12 percent loss in January and was
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.